Gideon Capital Advisors’s Boston Scientific BSX Stock Holding History

Gideon Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-43,059	Closed	-$1.95M	–	29
2019 Q4	$1.95M	Buy	+43,059	New	+$1.8M	0.67%	45
2019 Q3	–	Sell	-39,010	Closed	-$1.68M	–	293
2019 Q2	$1.68M	Buy	+39,010	New	+$1.5M	0.58%	48
2017 Q1	–	Sell	-13,459	Closed	-$292K	–	400
2016 Q4	$292K	Buy	+13,459	New	+$294K	0.19%	262
2014 Q4	–	Sell	-79,991	Closed	-$945K	–	215
2014 Q3	$945K	Buy	+79,991	New	+$1.01M	0.37%	92

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Gideon Capital Advisors's BSX Position: Q1 2020 in Review

Gideon Capital Advisors sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 43,059 shares — an estimated $1.95M sold.

Gideon Capital Advisors first reported a position in BSX in Q3 2014 and held it in 4 quarters. The position peaked at $1.95M in Q4 2019. 801 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

Gideon Capital Advisors reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
Gideon Capital Advisors sold 43,059 Boston Scientific shares in Q1 2020, an estimated $1.95M.
Gideon Capital Advisors first reported a position in Boston Scientific in Q3 2014 and held it in 4 quarters.
Gideon Capital Advisors's Boston Scientific position peaked at $1.95M in Q4 2019.
801 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Gideon Capital Advisors's 13F filing for Q1 2020.